S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
AAPL   262.64 (-0.69%)
FB   193.15 (-0.02%)
MSFT   148.06 (+0.51%)
GOOGL   1,309.15 (+1.00%)
AMZN   1,754.60 (+0.08%)
CGC   15.84 (-14.38%)
NVDA   209.79 (+0.58%)
MU   46.80 (+1.08%)
BABA   182.80 (+0.18%)
GE   11.29 (+0.00%)
TSLA   349.35 (+0.94%)
T   38.95 (-0.54%)
AMD   38.35 (+2.21%)
F   8.79 (-0.23%)
ACB   3.29 (-7.32%)
PRI   130.20 (+1.24%)
NFLX   289.62 (+2.30%)
BAC   32.70 (-0.27%)
GILD   63.81 (+0.76%)
DIS   147.15 (-1.06%)
S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
AAPL   262.64 (-0.69%)
FB   193.15 (-0.02%)
MSFT   148.06 (+0.51%)
GOOGL   1,309.15 (+1.00%)
AMZN   1,754.60 (+0.08%)
CGC   15.84 (-14.38%)
NVDA   209.79 (+0.58%)
MU   46.80 (+1.08%)
BABA   182.80 (+0.18%)
GE   11.29 (+0.00%)
TSLA   349.35 (+0.94%)
T   38.95 (-0.54%)
AMD   38.35 (+2.21%)
F   8.79 (-0.23%)
ACB   3.29 (-7.32%)
PRI   130.20 (+1.24%)
NFLX   289.62 (+2.30%)
BAC   32.70 (-0.27%)
GILD   63.81 (+0.76%)
DIS   147.15 (-1.06%)
S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
AAPL   262.64 (-0.69%)
FB   193.15 (-0.02%)
MSFT   148.06 (+0.51%)
GOOGL   1,309.15 (+1.00%)
AMZN   1,754.60 (+0.08%)
CGC   15.84 (-14.38%)
NVDA   209.79 (+0.58%)
MU   46.80 (+1.08%)
BABA   182.80 (+0.18%)
GE   11.29 (+0.00%)
TSLA   349.35 (+0.94%)
T   38.95 (-0.54%)
AMD   38.35 (+2.21%)
F   8.79 (-0.23%)
ACB   3.29 (-7.32%)
PRI   130.20 (+1.24%)
NFLX   289.62 (+2.30%)
BAC   32.70 (-0.27%)
GILD   63.81 (+0.76%)
DIS   147.15 (-1.06%)
S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
AAPL   262.64 (-0.69%)
FB   193.15 (-0.02%)
MSFT   148.06 (+0.51%)
GOOGL   1,309.15 (+1.00%)
AMZN   1,754.60 (+0.08%)
CGC   15.84 (-14.38%)
NVDA   209.79 (+0.58%)
MU   46.80 (+1.08%)
BABA   182.80 (+0.18%)
GE   11.29 (+0.00%)
TSLA   349.35 (+0.94%)
T   38.95 (-0.54%)
AMD   38.35 (+2.21%)
F   8.79 (-0.23%)
ACB   3.29 (-7.32%)
PRI   130.20 (+1.24%)
NFLX   289.62 (+2.30%)
BAC   32.70 (-0.27%)
GILD   63.81 (+0.76%)
DIS   147.15 (-1.06%)
Log in

Merck KGaA Stock Price, Forecast & Analysis (ETR:MRK)

€106.15
-3.60 (-3.28 %)
(As of 11/14/2019 04:00 PM ET)
Today's Range
€103.65
Now: €106.15
€109.95
50-Day Range
€100.15
MA: €105.32
€109.75
52-Week Range
€85.84
Now: €106.15
€108.95
Volume1.03 million shs
Average VolumeN/A
Market Capitalization$13.72 billion
P/E Ratio13.39
Dividend Yield1.17%
BetaN/A
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It offers prescription medicines to treat cancer, multiple sclerosis, infertility, growth deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, as well as squamous cell carcinoma of the head and neck; diagnostics and prescription drugs for allergen immunotherapy; and fertility treatments. The company also provides life science products and services for use in the discovery, development, and manufacture of drug therapies, as well as in laboratories; and specialty chemicals for use in displays, computer chips, surfaces, Integrated circuits, microelectronic systems, anti-reflection coatings, and cosmetics. It has alliances with Pfizer Inc., Bristol-Myers Squibb Company, Intrexon Corporation, Avillion LLP., F-star Delta Ltd, SFJ Pharmaceuticals Group, Alibaba Health, Checkmate Pharmaceuticals, Solvias, and Leap Therapeutics, Inc., as well as a collaboration with Daiichi Sankyo Company, Limited. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone49 6151 72 0

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$15.35 billion
Cash Flow€8.12 per share
Book Value€40.37 per share

Profitability

Miscellaneous

Employees51,039
Market Cap$13.72 billion
Next Earnings Date11/14/2019 (Estimated)
OptionableOptionable

Receive MRK News and Ratings via Email

Sign-up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter.


Merck KGaA (ETR:MRK) Frequently Asked Questions

What is Merck KGaA's stock symbol?

Merck KGaA trades on the ETR under the ticker symbol "MRK."

When is Merck KGaA's next earnings date?

Merck KGaA is scheduled to release their next quarterly earnings announcement on Thursday, November 14th 2019. View Earnings Estimates for Merck KGaA.

Has Merck KGaA been receiving favorable news coverage?

News coverage about MRK stock has trended somewhat negative this week, according to InfoTrie. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Merck KGaA earned a daily sentiment score of -1.4 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Merck KGaA.

Who are some of Merck KGaA's key competitors?

What other stocks do shareholders of Merck KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merck KGaA investors own include Nokia Oyj (NOKIA), Lanxess (LXS), Fresenius SE & Co KGaA (FRE), Siemens (SIE), Siemens Healthineers (SHL), SAP (SAP), Lanxess (LXS), Knorr - Bremse (KBX), HeidelbergCement (HEI) and Aixtron (AIXA).

Who are Merck KGaA's key executives?

Merck KGaA's management team includes the folowing people:
  • Dr. Stefan Oschmann, Chairman of Exec. Board & CEO (Age 62)
  • Dr. Marcus Kuhnert, CFO & Member of Exec. Board (Age 51)
  • Dr. Kai Beckmann, CEO of Performance Materials & Member of the Exec. Board (Age 54)
  • Dr. Udit Batra, CEO of Life Science & Member of Exec. Board (Age 48)
  • Ms. Belén Garijo López M.D., CEO of Healthcare & Member of the Exec. Board (Age 59)

What is Merck KGaA's stock price today?

One share of MRK stock can currently be purchased for approximately €106.15.

How big of a company is Merck KGaA?

Merck KGaA has a market capitalization of $13.72 billion and generates $15.35 billion in revenue each year. Merck KGaA employs 51,039 workers across the globe.View Additional Information About Merck KGaA.

What is Merck KGaA's official website?

The official website for Merck KGaA is http://www.merckgroup.com/.

How can I contact Merck KGaA?

The company can be reached via phone at 49 6151 72 0.


MarketBeat Community Rating for Merck KGaA (ETR MRK)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  28 (Vote Outperform)
Underperform Votes:  22 (Vote Underperform)
Total Votes:  50
MarketBeat's community ratings are surveys of what our community members think about Merck KGaA and other stocks. Vote "Outperform" if you believe MRK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MRK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/14/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel